WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

China's Clinical Trial Quality Management Faces Key Challenges Despite Progres... A recent systematic review published in Frontiers in Medicine examines the evolution of clinical trial quality management in China, highlighting both advances and challen...
(9/2/2025)

China's Biopharma Industry Clusters: Mapping O... (9/3/2025)

China's Clinical Trial Quality Management Face... (9/2/2025)

AstraZeneca Bounces Back from Scandal in China... (8/27/2025)

Global Pharma Funnels $48.5B into Chinese Biot... (8/27/2025)

Premier Li Visits BeOne, Signaling China's Str... (8/22/2025)

On the Cusp of a Cure: Is Asia Pacific Ready f... (8/20/2025)

Six Key Insights Into China Biotech's NewCo Mo... (8/19/2025)

Leaving China Manufacturing: The Hidden Risks ... (8/19/2025)

Adjudication Of Drug Patent Linkage Cases When... (8/19/2025)

U.S. Tariffs Pressure Mounting, Japanese Pharm... (8/19/2025)

China Sees Surge in Innovative Drug Approvals ... (8/14/2025)

The Trends Shaping Chinese Pharma Patent Litig... (8/13/2025)

Astellas Accelerates Growth and Innovati... (9/2/2025) Nine First-in-Class Drugs Receive Initia... (9/2/2025) Novatim and Radiance Forge Global Licens... (9/2/2025) China Approved Seven New Drugs in August (9/2/2025) BioNTech Launches Phase 1/2 Trial of BNT... (9/1/2025) Fosun Licenses Accro’s TYK2/JAK1 Inhibi... (9/1/2025) Hongcheng Launches Phase II Trial for PD... (9/1/2025) Ennovabio Secures New Financing to Advan... (9/1/2025) Novel iPSC-Derived Neural Cell Therapy S... (9/1/2025) Convalife's HKEX IPO Application Gets G... (9/1/2025) Hengrui Seeks NMPA Approval for New Dual... (9/1/2025) Recent Executive Moves (8/30/2025) CMS Subsidiary Gets Approval to Launch C... (8/30/2025) Eli Lilly Partners with JD Health for Po... (8/29/2025) Fosun Secures Exclusive Rights to ACCRO... (8/29/2025) Adcoris Raises CNY Tens of Millions to ... (8/29/2025) MagicRNA Raises ~CNY 100M in Pre-A+ Fin... (8/29/2025) D3 Bio's D3S-001 Receives FDA Breakthru ... (8/29/2025)

China Drives Asia-Pacific Health Care Transformation Am... China's Innovative Drug Market Surpasses CNY 400 Billio... China's 'Silver Yuan' Set to Power US$134B Boom in Geri... China Hospitals Prioritize Local Innovation, Digital He... China's Pharma Market Faces Mixed Performance in Q1 202...

Novatim and Radiance Forge Global Licensing Deal for No... Astellas Accelerates Growth and Innovation in China Convalife's HKEX IPO Application Gets Green Light Ennovabio Secures New Financing to Advance Pipeline for... Fosun Licenses Accro’s TYK2/JAK1 Inhibitor AC-201 in G...

CDE Seeks Comment on ICH E6(R3) GCP Implementation Reco... CDE Solicits Comments on Draft Guideline for Post-Appro... CDE Invites Public Comment on 97th Batch of Reference F... CDE Issues Technical Guideline for Non-Clinical Researc... CDE Issues Draft Requirements for Module ...

NHSA Announces Results of Form Review for 2025 NRDL Sub... China Unveils Nine Key Healthcare Insurance Priorities ... NHSA Issues Interim Measures for Disease-Based Medical ... NHSA Publishes Preliminary Review Results for 2025 NRDL... China Launches 11th National VBP Round with New Flexibi...

Chinese Scientist Arrested in Houston Over Alleged Thef... U.S. Closes Bribery Investigation into GE Healthcare's ... SAMR Orders Simcere to Reverse Unnotified Merger Over C... U.S. Lawmakers Raise Fresh Alarm Over GenScript's China... Record China Pharma Monopoly Fine Sends Strong Deterren...

India Moves to Set Minimum Import Prices to Protect Pha... China Struggles to Maintain Grip on India's Bulk Drug M... API China 2025 Ends with High Attendance and Global Ind... FDA Issues Warning Letters to Two Chinese API Manufactu... Implications of China's Growing Influence in Global Pha...

China Approved Seven New Drugs in August Nine First-in-Class Drugs Receive Initial Clinical Appr... Hengrui Seeks NMPA Approval for New Dual-Receptor Obesi... Novel iPSC-Derived Neural Cell Therapy Shows Promise in... Hongcheng Launches Phase II Trial for PD-1/CTLA-4/VEGF ...

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Executive Moves Recent Executive Moves Recent Executive Moves Recent Official and Executive Moves Recent Official and Executive Moves

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...